Status: Recruiting
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
To compare MW-III to Silvadene® Cream 1% (Silver Sulfadiazine) with respect to "time to healing" (≥95% re-epithelialization) of a partial thickness target thermal burn.
Participants needed: 60
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Skingenix, Inc.Updated: Mar 16, 2026Locations: 6
Eligibility criteria
Adults, 18 years of age or older on the day of signing the informed consent. [+2]
infected. [+3]